Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 259

    1.

    Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.

    Gupta AK, Dahlof B, Dobson J, Sever PS, Wedel H, Poulter NR; Anglo-Scandinavian Cardiac Outcomes Trial Investigators.

    Diabetes Care. 2008 May;31(5):982-8. Epub 2008 Jan 30.PMID: 18235048 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.

    Dolan E, Stanton AV, Thom S, Caulfield M, Atkins N, McInnes G, Collier D, Dicker P, O'Brien E; ASCOT Investigators.

    J Hypertens. 2009 Apr;27(4):876-85.PMID: 19516185 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

    Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators.

    Lancet. 2005 Sep 10-16;366(9489):895-906.PMID: 16154016 [PubMed - indexed for MEDLINE]Related articles

    4.

    The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.

    Ostergren J, Poulter NR, Sever PS, Dahlöf B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E; ASCOT investigators.

    J Hypertens. 2008 Nov;26(11):2103-11.PMID: 18854748 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.

    Sever PS, Poulter NR, Dahlof B, Wedel H; ASCOT Investigators.

    J Hypertens. 2009 May;27(5):947-54.PMID: 19318984 [PubMed - indexed for MEDLINE]Related articles

    6.

    Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).

    Poulter NR, Dobson JE, Sever PS, Dahlöf B, Wedel H, Campbell NR; ASCOT Investigators.

    J Am Coll Cardiol. 2009 Sep 22;54(13):1154-61.PMID: 19761936 [PubMed - indexed for MEDLINE]Related articles

    7.

    The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.

    Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT investigators.

    Pharmacoeconomics. 2009;27(3):221-30. doi: 10.2165/00019053-200927030-00005.PMID: 19354342 [PubMed - indexed for MEDLINE]Related articles

    8.

    [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers]

    van den Meiracker AH, van Montfrans GA.

    Ned Tijdschr Geneeskd. 2006 Apr 22;150(16):886-8. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2006 May 13;150(19):1100. PMID: 16686086 [PubMed - indexed for MEDLINE]Related articles

    9.

    Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.

    Aksnes TA, Kjeldsen SE, Rostrup M, Störset O, Hua TA, Julius S.

    J Hum Hypertens. 2008 Aug;22(8):520-7. Epub 2008 May 29.PMID: 18509347 [PubMed - indexed for MEDLINE]Related articles

    10.

    Coronary heart disease benefits from blood pressure and lipid-lowering.

    Sever PS, Poulter NR, Mastorantonakis S, Chang CL, Dahlof B, Wedel H; ASCOT Investigators.

    Int J Cardiol. 2009 Jun 26;135(2):218-22. Epub 2009 Feb 20.PMID: 19232755 [PubMed - indexed for MEDLINE]Related articles

    11.

    Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

    Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F.

    Diabetes Care. 1998 Apr;21(4):597-603.PMID: 9571349 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

    Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S; LIFE study group.

    J Hypertens. 2002 Sep;20(9):1879-86.PMID: 12195132 [PubMed - indexed for MEDLINE]Related articles

    13.

    Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.

    Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, Mehlsen J, Nieminem M, O'Brien E, Ostergren J; ASCOT Steering Committee Members.

    Eur Heart J. 2006 Dec;27(24):2982-8. Epub 2006 Dec 4. Erratum in: Eur Heart J. 2007 Jan;28(1):142. PMID: 17145722 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

    Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee.

    Circulation. 2006 Mar 7;113(9):1213-25. Epub 2006 Feb 13.PMID: 16476843 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension.

    Meurin P.

    Am J Cardiovasc Drugs. 2006;6(5):327-34. Review.PMID: 17083267 [PubMed - indexed for MEDLINE]Related articles

    16.

    Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.

    Kjeldsen SE, McInnes GT, Mancia G, Hua TA, Julius S, Weber MA, Coca A, Girerd X, Jamerson K, Larochelle P, Macdonald T, Schmieder RE, Anthony Schork M, Viskoper R, Widimsky J, Zanchetti A.

    Blood Press. 2008;17(3):170-7.PMID: 18608200 [PubMed - indexed for MEDLINE]Related articles

    17.

    Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

    Poulter NR, Wedel H, Dahlöf B, Sever PS, Beevers DG, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, Pocock S; ASCOT Investigators.

    Lancet. 2005 Sep 10-16;366(9489):907-13.PMID: 16154017 [PubMed - indexed for MEDLINE]Related articles

    18.

    The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.

    Sever PS, Poulter NR, Dahlof B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes G, Mehlsen J, Nieminen MS, O'Brien ET, Ostergren J; ASCOT Investigators.

    Eur Heart J. 2008 Feb;29(4):499-508. Epub 2008 Jan 5.PMID: 18175773 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group.

    Arch Intern Med. 2006 Nov 13;166(20):2191-201.PMID: 17101936 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

    Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

    Circulation. 2006 May 9;113(18):2201-10. Epub 2006 May 1.PMID: 16651474 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data